Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 9Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Oropharyngeal Neoplasms 7Mouth Neoplasms 7Laryngeal Neoplasms 7Carcinoma 6Hypopharyngeal Neoplasms 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 3Nasopharyngeal Carcinoma 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Paranasal Sinus Neoplasms 2Lymphoid Interstitial Pneumonia 2Cholangiocarcinoma 2Anus Neoplasms 2Adenocarcinoma of Lung 2Urethral Neoplasms 1Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Stomatitis 1Stomach Neoplasms 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sinonasal undifferentiated carcinoma 1Sinonasal Squamous Cell Carcinoma 1Sertoli-Leydig Cell Tumor 1

Interventions

Gemcitabine 6Specimen Handling 4Cisplatin 4pembrolizumab 3enfortumab vedotin 3atezolizumab 3Nivolumab 3Magnetic Resonance Spectroscopy 3Carboplatin 3vinflunine 2eribulin 2avelumab 2Standard of Care 2Biopsy 2vandetanib 1tocilizumab 1tamibarotene 1rucaparib 1relatlimab 1pegfilgrastim 1merphos 1guadecitabine 1genexol-PM 1dehydroftorafur 1carotuximab 1Vitamin D 1Vinblastine 1Ramucirumab 1Radiotherapy 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Ureteral Neoplasms × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT03617913 2023-01-06

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

Mayo Clinic

Phase 2 Completed
2 enrolled 8 charts
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡